Education
About Us
Working with TipRanks
Follow Us
Oragenics Inc (OGEN)
:OGEN
Total Valuation
Oragenics has a market cap or net worth of $3.81M. The enterprise value is $4.95M.
Market Cap$3.81M
Enterprise Value$4.95M
Share Statistics
Oragenics has 4,168,223 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,168,223
Owned by Insiders2.68%
Owned by Institutions2.90%
Financial Efficiency
Oragenics’s return on equity (ROE) is 49.88 and return on invested capital (ROIC) is -9052.41%.
Return on Equity (ROE)49.88
Return on Assets (ROA)-7.18
Return on Invested Capital (ROIC)-9052.41%
Return on Capital Employed (ROCE)49.83
Revenue Per Employee0.00
Profits Per Employee-3.52M
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Oragenics is ―. Oragenics’s PEG ratio is 0.08.
PE Ratio―
PS Ratio0.00
PB Ratio-346.28
Price to Fair Value-346.28
Price to FCF-8.53
Price to Operating Cash Flow>-0.01
PEG Ratio0.08
Income Statement
In the last 12 months, Oragenics had revenue of 0.00 and earned -10.57M in profits. Earnings per share was -1.60.
Revenue0.00
Gross Profit0.00
Operating Income-10.56M
Pretax Income-10.57M
Net Income-10.57M
EBITDA-10.54M
Earnings Per Share (EPS)-1.60
Cash Flow
In the last 12 months, operating cash flow was -8.43M and capital expenditures 0.00, giving a free cash flow of -8.43M billion.
Operating Cash Flow-8.43M
Free Cash Flow-8.43M
Free Cash Flow per Share-2.02
Dividends & Yields
Oragenics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.03
52-Week Price Change-91.98%
50-Day Moving Average1.13
200-Day Moving Average3.11
Relative Strength Index (RSI)32.77
Average Volume (3m)211.78K
Important Dates
Oragenics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Oragenics as a current ratio of 0.87, with Debt / Equity ratio of -141.00%
Current Ratio0.87
Quick Ratio0.87
Debt to Market Cap<0.01
Net Debt to EBITDA0.05
Interest Coverage Ratio-354.00
Taxes
In the past 12 months, Oragenics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Oragenics EV to EBITDA ratio is -6.90, with an EV/FCF ratio of -8.47.
EV to Sales0.00
EV to EBITDA-6.90
EV to Free Cash Flow-8.47
EV to Operating Cash Flow-8.47
Balance Sheet
Oragenics has $11.40M in cash and marketable securities with $394.84K in debt, giving a net cash position of $11.01M billion.
Cash & Marketable Securities$11.40M
Total Debt$394.84K
Net Cash$11.01M
Net Cash Per Share$2.64
Tangible Book Value Per Share-$0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Oragenics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast90.27%